Technological knowledge base, R&D organization structure and alliance formation: Evidence from the biopharmaceutical industry
AbstractWe explore how an incumbent firm's internal knowledge and organization structure influences its strategic alliance formation. We propose that the firm's knowledge breadth and the centrality of its R&D organization structure positively influence its absorptive capacity, and consequently, its propensity to form strategic alliances. We also argue that the centrality of the R&D organization structure may be a substitute for the breadth of the knowledge base. We validate our ideas using data on 2647 strategic alliances formed over the period of 1993â2002 by 43 major biopharmaceutical firms in the U.S. and Europe. Our discussion focuses on the application of the knowledge-based view of the firm to strategic alliance research. The implications for public policy in the biopharmaceutical industry are also emphasized.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Bibliographic InfoArticle provided by Elsevier in its journal Research Policy.
Volume (Year): 36 (2007)
Issue (Month): 4 (May)
Contact details of provider:
Web page: http://www.elsevier.com/locate/respol
Other versions of this item:
- Jing Zhang & Charles Baden-Fuller & Vincent Mangematin, 2007. "Technological Knowledge Base, R&D Organization Structure and Alliance Formation: Evidence from the Biopharmaceutical Industry," Grenoble Ecole de Management (Post-Print) hal-00424512, HAL.
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Henderson, Rebecca. & Cockburn, Iain., 1994. "Measuring competence? : exploring firm effects in pharmaceutical research," Working papers 3712-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
- Eric Avenel & Anne-Violaine Favier & Simon Ma & Vincent Mangematin & Carole Rieu, 2007.
"Diversification and hybridization in firm knowledge bases in nanotechnologies,"
Grenoble Ecole de Management (Post-Print)
- Avenel, E. & Favier, A.V. & Ma, S. & Mangematin, V. & Rieu, C., 2007. "Diversification and hybridization in firm knowledge bases in nanotechnologies," Research Policy, Elsevier, vol. 36(6), pages 864-870, July.
- Avenel, E. & Favier, A.V. & Ma, S. & Mangematin V. & Rieu, C., 2006. "Diversification and hybridisation in firm knowledge bases in nanotechnologies," Working Papers 200602, Grenoble Applied Economics Laboratory (GAEL).
- Eric Avenel & Anne-Violaine Favier & Simon Ma & Vincent Mangematin & Carole Rieu, 2007. "Diversification and hybridization in firm knowledge bases in nanotechnologies," Post-Print hal-00424531, HAL.
- Haeussler, Carolin & Patzelt, Holger & Zahra, Shaker A., 2012. "Strategic alliances and product development in high technology new firms: The moderating effect of technological capabilities," Journal of Business Venturing, Elsevier, vol. 27(2), pages 217-233.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Zhang, Lei).
If references are entirely missing, you can add them using this form.